Mankind Pharma Limited

NSEI:MANKIND Stok Raporu

Piyasa değeri: ₹1.1t

Mankind Pharma Temettü

Temettü kriter kontrolleri 0/6

Mankind Pharma does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisin/a
Gelecekteki Temettü Verimi0.4%
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly

Aug 26
Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly

Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)

Jul 12
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)

Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors

May 08
Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors

Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't

Apr 08
Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't

Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 04
Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if MANKIND's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if MANKIND's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Mankind Pharma Piyasaya Karşı Temettü Getirisi
MANKIND temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (MANKIND)n/a
Pazarın Alt %25'i (IN)0.2%
Pazarın En İyi %25'i (IN)1.1%
Sektör Ortalaması (Pharmaceuticals)0.7%
Analist tahmini (MANKIND) (3 yıla kadar)0.4%

Önemli Temettü: Unable to evaluate MANKIND's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate MANKIND's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate MANKIND's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as MANKIND has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin